Newer Drugs Not Cost-Effective for First-Line Diabetes Therapy ...Middle East

Medscape - News
Costs of SGLT2 inhibitors and GLP-1 receptor agonists 'need to be lowered substantially' to improve health outcomes and prevent health disparities in patients with type 2 diabetes, say researchers. Medscape Medical News

Hence then, the article about newer drugs not cost effective for first line diabetes therapy was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Newer Drugs Not Cost-Effective for First-Line Diabetes Therapy )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News